Lurbinectedin is a chemotherapy drug that is used to treat certain types of cancer, such as small cell lung cancer. However, there is no information available on whether it can be given to premature infants. The drug patent information [1] and FDA document [2] do not mention anything about the use of lurbinectedin in premature infants. Additionally, the National Cancer Institute's dictionary of cancer drugs [3] does not provide any information on the use of lurbinectedin in pediatric patients, let alone premature infants.

It is important to note that chemotherapy drugs are typically not given to premature infants unless absolutely necessary, as their organs are not fully developed and may not be able to handle the toxicity of the drugs. Additionally, the dosage and administration of chemotherapy drugs in premature infants would need to be carefully considered and monitored by a healthcare professional.

In summary, there is no information available on whether lurbinectedin can be given to premature infants. As with any medication, the use of lurbinectedin in premature infants would need to be carefully considered and monitored by a healthcare professional.

Sources:
[1] https://www.drugpatentwatch.com/p/tradename/LURBINECTEDIN
[2] https://www.fda.gov/media/105933/download
[3] https://www.cancer.gov/publications/dictionaries/cancer-drug